ABOUT ABBV-744 AS A POTENTIAL THERAPEUTIC OPTION FOR AGGRESSIVE CANCERS

These side effects were notably milder compared to an inhibitor of both bromodomains. A detailed molecular Examination also revealed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen TaylorCelastrol was discovered to be a Myb inhibitor that suppressed C/EBPβ exercise and repressed AML cel